psilocybin – A New Vision for Mental Health

Australia legalises psychedelics for mental health

Author: Editorial 3rd July 2023 0 Comments

Tiffany Wertheimer reports for the BBC: “Australia has become the first country in the world to legalise the use of psychedelics to treat some mental health conditions. Approved psychiatrists can now prescribe MDMA to those suffering post-traumatic stress disorder and magic…
Read more

collaborative practice

Australia, BBC, depression, magic mushrooms, MDMA, New Approaches, psilocybin, Psychedelic-assisted therapy, PTSD, Therapeutic Goods Administration, Tiffany Wertheimer

Psychedelics: The revolutionary drugs that could change your life – a guide from the expert

Author: Editorial 31st May 2023 0 Comments

This book has been written by Prof. David Nutt. The publishers say: “We are on the cusp of a major revolution in psychiatric medicine and neuroscience. After fifty years of prohibition, criminalisation and fear, science is finally showing us that psychedelics…
Read more

collaborative practice

ayahuasca, books, David Nutt, depression, Ketamine, LSD, magic mushrooms, MDMA, Neuropsychopharmacology, neuroscience, OCD, psilocybin, psychedelic drugs, PTSD

My Mind Medicine Australia Psychedelic Lecture Tour

Author: Editorial 8th March 2023 0 Comments

This article by Prof. David Nutt has been published by Drug Science. It begins: “I have just come back from a 3-week lecture tour of South-Eastern Australia supporting the cause of the charity Mind Medicine Australia (MMA) They have been raising money for psychedelic…
Read more

collaborative practice

Australia, David Nutt, Drug Science, MDMA, Mind Medicine Australia, psilocybin, Psychedelic-assisted therapy, Randomised Control Trials (RCTs), Real World Evidence, Research

Australia to allow prescription of MDMA and psilocybin for treatment-resistant mental illnesses

Author: Editorial 6th February 2023 0 Comments

“… the decision will make Australia the first country in the world to officially recognise MDMA and psilocybin as medicines” This report (from Tory Shepherd for The Guardian) begins: “After decades of ‘demonisation’, psychiatrists will be able to prescribe MDMA and…
Read more

collaborative practice

Australia, David Caldicott, depression, MDMA, New Approaches, Post-Traumatic-Stress-Disorder, psilocybin, PTSD, The Guardian, Therapeutic Goods Administration, Tory Shepherd

The Top 10 Psychedelic Science Studies Of 2022

Author: Editorial 19th January 2023 0 Comments

This article by Zeus Tipado has been published by HealingMaps. It begins: “Before you can assemble a list of the top ten greatest psychedelic science studies of 2022, you must first read every psychedelic study of 2022. I cannot stress enough…
Read more

collaborative practice

HealingMaps, inflammation, Ketamine, lysergic acid diethylamide (LSD), MDMA, music therapy, Nature Relatedness, neuroscience, psilocybin, Psychedelic Drug Trial, Research, stress, Zeus Tipado

Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial

Author: Editorial 3rd January 2023 0 Comments

This research paper has been published in eClinicalMedicine. The summary says: “Background Psilocybin has been suggested as a novel, rapid-acting treatment for depression. Two consecutive doses have been shown to markedly decrease symptom severity in an open-label setting or when compared to…
Read more

collaborative practice

depression, eClinicalMedicine, efficacy, magic mushrooms, Placebo-controlled, psilocybin, Psychedelic-assisted therapy, Randomised Control Trials (RCTs), RCT, Research

Magic-mushroom drug can treat severe depression, trial suggests

Author: Editorial 3rd November 2022 0 Comments

This report by Philippa Roxby comes from the BBC. It begins: “A drug based on a compound in hallucinogenic mushrooms can improve the symptoms of severe depression for up to 12 weeks, a trial shows. A 25mg tablet of psilocybin puts…
Read more

collaborative practice

Andrew McIntosh, BBC, depression, magic mushrooms, New England Journal of Medicine, Philippa Roxby, psilocybin, psychotherapy, Research, severe depression

New study determines psychedelic mushroom microdoses can improve mood, mental health

Author: Editorial 20th July 2022 0 Comments

As reported on the MedicalXpress website, research from the University of British Columbia is … “The latest study to examine how tiny amounts of psychedelics can impact mental health provides further evidence of the therapeutic potential of microdosing. Published in Scientific Reports this…
Read more

collaborative practice

anxiety, depression, Joseph Rootman, MedicalXpress, Microdose.me, microdosing, New Approaches, psilocybin, psychomotor ability, Research, Scientific Reports, stress, University of British Columbia, Zach Walsh

Psychedelic frees up depressed brain, study shows

Author: Editorial 13th May 2022 0 Comments

Philippa Roxby reports for the BBC: “Psilocybin, a drug found in magic mushrooms, appears to free up the brains of people with severe depression in a way that other antidepressants do not, a study has found. The results, based on brain…
Read more

collaborative practice

antidepressants, BBC, Centre for Psychedelic Research, David Nutt, depression, Imperial College London, Nature Medicine, neuroscience, Philippa Roxby, psilocybin, Research

Psilocybin: British study finds ‘magic mushroom’ drug can be safely used to treat depression

Author: Editorial 8th April 2022 0 Comments

Sky News reports : “A groundbreaking British study has found that the psychedelic drug psilocybin can be safely given to patients, and may be used to treat a range of mental health conditions. Recreational use of the drug – isolated from…
Read more

collaborative practice

COMPASS Pathways, Journal of Psychopharmacology, King's College London, psilocybin, Sky News